$12.09
Price
$645M
Market Cap
9.2
P/E Ratio
4.0
Forward P/E
$1.32
EPS (TTM)
—
Dividend Yield
$246M
Cash
$664M
Total Debt
53M
Shares Out
$4.02
$14.06
52-Week Range
Institutional Ownership of EMERGENT BIOSOLUTIONS INC
|
Fund / Manager
Click to search
|
Shares | Value | % of Portfolio | Cost Basis | Est. Return |
|---|---|---|---|---|---|
| No funds currently hold this stock. | |||||
Trading Activity for EMERGENT BIOSOLUTIONS INC
|
Fund / Manager
Click to search
|
Action | Change | Shares After | Value | Price |
|---|---|---|---|---|---|
| No activity found for this stock. | |||||
Insider Trading for EMERGENT BIOSOLUTIONS INC
6 Months Insider Sentiment
Buy $0
Sell $842K
0
Buys
5
Sells
-842K
Net
0
Grants
Largest
$306K
Glessner
$188K
Degolyer
$177K
Richard
| Date |
Insider
Click to search
|
Role
Click to search
|
Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Dec 05, 2025 | Ronald Richard | Director | EXERCISE | 25.7K | $5.02 | $129K |
| Dec 05, 2025 | Ronald Richard | Director | SELL | 7.1K | $12.11 | $86K |
| Dec 05, 2025 | Ronald Richard | Director | SELL | 14.9K | $11.90 | $177K |
| Nov 10, 2025 | Donald W Degolyer | Director | SELL | 17.8K | $10.54 | $188K |
| Nov 07, 2025 | Sujata Tyagi Dayal | Director | SELL | 8.6K | $10.00 | $86K |
| Oct 07, 2025 | Coleen Glessner | EVP, Quality & Ethics, and CPL | SELL | 30.6K | $10.00 | $306K |